Journals / Meandros Medical And Dental Journal / 2016 / Cilt: 17 - Sayı: 1

Cyclooxygenase-2 and Vascular Endothelial Growth Factor Expression and Their Correlation with Angiogenesis in Gastric Carcinomas

Gastrik Karsinomlarda Siklooksijenaz-2, Vasküler Endotelyal Büyüme Faktörü Ekspresyonu ve Anjiyogenezisle İlişkisi

Pages
1–10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There was no correlation of clinicopathological parameters with COX-2 and VEGF expression and MVD grade.Conclusion: Our results suggest that the MVD in gastric carcinoma may correlate with tumor grade, but the precise roles of COX-2 and VEGF in gastric cancers are not yet fully understood.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study was to investigate the expression of cyclooxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF) in gastric carcinomas and lymph node metastasis and their relationship with angiogenesis and prognostic histopathological parameters.Materials and Methods: COX-2 and VEGF expression and microvessel density (MVD) grade identified by antibodies against CD34 were investigated immunohistochemically in 33 patients with gastric carcinoma.
📊
Key Findings & Data:Results: The expression of COX-2 was 96.9% in normal mucosa and 87.8% in gastric carcinoma.
💡
Conclusion & Impact:There was no correlation of clinicopathological parameters with COX-2 and VEGF expression and MVD grade.Conclusion: Our results suggest that the MVD in gastric carcinoma may correlate with tumor grade, but the precise roles of COX-2 and VEGF in gastric cancers are not yet fully understood.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of this study was to investigate the expression of cyclooxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF) in gastric carcinomas and lymph node metastasis and their relationship with angiogenesis and prognostic histopathological parameters.Materials and Methods: COX-2 and VEGF expression and microvessel density (MVD) grade identified by antibodies against CD34 were investigated immunohistochemically in 33 patients with gastric carcinoma. Results: The expression of COX-2 was 96.9% in normal mucosa and 87.8% in gastric carcinoma. Although COX-2 expression in mucosa was higher than in carcinoma, the difference was not statistically significant. The COX-2 positivity rates in lymph nodes were significantly higher in patients with vascular invasion (p<0.01). The expression of VEGF was 100% in normal mucosa and 93.9% in gastric carcinoma. VEGF levels in mucosa were significantly higher than in carcinoma (p=0.05). MVD grade in mucosa was significantly higher than in gastric carcinoma (p<0.01). MVD values were significantly higher in poorly differentiated carcinomas than in well and moderately differentiated carcinomas (p<0.05). There was no association between COX-2 and VEGF expression and MVD grade in tumor tissues and metastatic lymph nodes. There was no correlation of clinicopathological parameters with COX-2 and VEGF expression and MVD grade.Conclusion: Our results suggest that the MVD in gastric carcinoma may correlate with tumor grade, but the precise roles of COX-2 and VEGF in gastric cancers are not yet fully understood. Further studies with large series are needed to clarify the importance of COX-2, VEGF and MVD in cancer progression.

Özet

Amaç: Bu çalışmanın amacı, mide karsinomları ile bunların lenf nodu metastazlarında siklooksijenaz-2 (COX-2) ve vasküler endotelyal büyüme (growth) faktörü (VEGF) immün reaktivitelerini belirlemek, bunların anjiyogenezle ve histopatolojik prognostik parametrelerle olan ilişkisini araştırmaktır.Gereç ve Yöntemler: Otuz üç gastrik karsinom olgusunda immünhistokimyasal yöntemlerle COX-2, VEGF ekspresyonu ve CD34 ile belirlenen mikrodamar dansitesi (MVD) derecesi incelendi.Bulgular: COX-2 ile normal mukoza %96,9, karsinom grubu %87,8 oranında pozitif boyandı. Tümördeki COX-2 boyanma derecesi ile mukozadaki COX-2 boyanma derecesi arasında istatistiksel olarak anlamlı bir fark izlenmedi. Damar invazyonu pozitif olguların COX-2 ile lenf nodu boyanma derecesi anlamlı olarak daha yüksek idi (p<0,01). VEGF ile normal mukoza %100, karsinom grubu %93,9 oranında pozitif boyandı. Normal mukoza karsinom grubuna kıyasla VEGF ile anlamlı olarak daha yüksek oranda pozitiflik gösterdi (p=0,05). MVD derecesi tümöre kıyasla mukozada daha fazla idi (p<0,01). Kötü diferansiye karsinomlar, iyi ve orta derecede diferansiye karsinomlara göre anlamlı olarak daha yüksek MVD derecesine sahipti (p<0,05). Tümörde ve metastatik lenf nodlarında COX-2 ve VEGF ekspresyonu ile MVD derecesi arasında herhangi bir ilişki tespit edilmedi. COX-2, VEGF ve MVD derecesinin klinikopatolojik parametrelerle ilişkisi istatistiksel olarak anlamlı bulunmadı.Sonuç: Bu bulgulara göre gastrik karsinomlarda MVD derecesi artarken, tümör diferansiasyonu azalıyor olabilir, fakat COX-2 ve VEGF'nin gastrik karsinom gelişimindeki rolü henüz tam olarak anlaşılamamıştır. COX-2, VEGF ve MVD derecesinin gastrik karsinogenezis sürecindeki yerini tam olarak açığa kavuşturabilmek için daha geniş serilerle ileri çalışmalara gereksinim vardır.

🔖

Cite This Article

EKİCİ, Ö., TOKYOL, Ç., DİLEK, F. H., AKTEPE, F., ŞAHİN, Ö., ŞAHİN, D. A. (2016). Cyclooxygenase-2 and Vascular Endothelial Growth Factor Expression and Their Correlation with Angiogenesis in Gastric Carcinomas. Meandros Medical And Dental Journal, Cilt: 17 - Sayı: 1, 1–10. https://ajindex.com/articles/282886

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Liu C, Crawford JM. The Gastrointestinal Tract. In: Kumar V, Abbas AK, Fausto N (eds). Robbins Pathologic Basis of Disease. 7th ed. China: Elsevier Saunders, 2005: 797-76. Rosai J. Gastrointestinal Tract. In: Rosai J (ed). Rosai and Ackerman's Surgical Pathology. 9th ed. Edinburgh: Mosby, 2004: 648-711.
  2. Göçmen E, Kocaoğlu H. Mide Kanseri Epidemiyolojisi. Türkiye Klinikleri Cerrahi Dergisi 2000; 15: 161-2.
  3. Kumar V, Abbas AK, Fausto N. Acute and Chronic Inflammation. In: Kumar V, Abbas AK, Fausto N (eds). Robbins Pathologic Basis of Disease. 7th ed. China: Elsevier Saunders, 2005: 47-86.
  4. Kumar V, Abbas AK, Fausto N. Neoplasia. In: Kumar V, Abbas AK, Fausto N (eds). Robbins Pathologic Basis of Disease. 7th ed. China: Elsevier Saunders, 2005: 269-342.
  5. Weidner N, Semole JP, Welch WR, Folkman J. Tumor angiogenesis and metastases correlation in invasive breast carcinoma. N Eng J Med 1991; 324: 1-8.
  6. Bosari S, Lee AK, De Lelli S, Willey BD, Heatly GJ, Silverman ML. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 1992; 23: 755-61.
  7. Kumar V, Abbas AK, Fausto N. Tissue Renewal and Repair: Regeneration, Healing, and Fibrosis. In: Kumar V, Abbas AK, Fausto N (eds). Robbins Pathologic Basis of Disease. 7th ed. China: Elsevier Saunders, 2005: 87-118. Topak N. Kolon karsinogenezisinde siklooksijenazların rolü. Uzmanlık Tezi, Afyonkarahisar: Afyon Kocatepe Üniversitesi Tıp Fakültesi Patoloji Anabilim Dalı, 2007.
  8. Folkman J, Watson K, Ingber D, Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989; 339: 58-61.
  9. Brooks P, Emery P, Evans JF. Interpreting the clinical signifance of the differantial inhibition of cyclooxygenase-2. Rheumatology 1999; 38: 779-88.
  10. Buskens CJ, Sivula A, Van Rees BP, Haglund C, Offerhaus GJ, van Lanschot JJ, et al. Comparison of cyclooxygenase-2 expression in adenocarcinomas of the gastric cardia and distal oesophagus. Gut 2003; 52: 1678-83.
  11. Bottone FG, Martinez JM, Alston-Mills B, Eling TE. Gene modulation by COX-1 and COX-2 spesific inhibitors in human colorectal carcinoma cancer cells. Carcinogenesis 2004; 25: 349- 57. Cheng T, Cao W, Wen R, Steinberg RH, Lavail MM. Prostaglandin E2 induces vascular endothelial growth factor expression and basic fibroblast growth factor mRNA expression in cultured rat Müller cells. Invest Ophthalmol Vis Sci 1998; 39: 581-91.
  12. Ben-Av P, Crofford LJ, Wilder RL, Hla T. Induction of vascular endothelial growth factor expression in synovial fib